Doctor profile · Federal record
Dr. Hosam Saad-Naguib, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Dalton, GA
- NPI 1861473472
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1504 N Thornton Ave, Suite 102
Dalton, GA 307208394
(706) 226-0508
fax (706) 226-5889
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Georgia #039456
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1861473472. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
99,774
Distinct HCPCS
10
Medicare allowed
$1,274,499
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 63,750 | 39 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 14,200 | 11 | $54 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 7,950 | 14 | $3 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 3,401 | 503 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,878 | 38 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 2,833 | 487 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 898 | 386 | $119 | |
96372 |
Injection of drug or substance under skin or into muscle | 441 | 84 | $13 | |
99211 |
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 391 | 96 | $21 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 363 | 53 | $115 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 2,360. This provider delivers 42× the peer median.Open Payments
Industry payments received
All-time total
$195
Transactions
8
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| TerSera Therapeutics LLC | 1 | $35.11 | |
| Novartis Pharmaceuticals Corporation | 1 | $26.99 | |
| Daiichi Sankyo Inc. | 1 | $26.68 | |
| ABBVIE INC. | 1 | $24.66 | |
| Astellas Pharma US Inc | 1 | $24.65 | |
| Eisai Inc. | 1 | $22.06 | |
| Merck Sharp & Dohme LLC | 1 | $18.29 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $17.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
806
Patients
195
Total drug cost
$1,727,598
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 200 | 39 | $4,370 |
| Potassium Chloride | Generic | 118 | 41 | $1,779 |
| Eliquis (Apixaban) | Brand | 54 | 0 | $32,452 |
| Hydroxyurea | Generic | 50 | 12 | $1,748 |
| Prochlorperazine Maleate | Generic | 47 | 28 | $706 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 44 | 0 | $874,719 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 42 | 15 | $550 |
| Dexamethasone | Generic | 40 | 26 | $924 |
| Revlimid (Lenalidomide) | Brand | 40 | 0 | $739,292 |
| Ondansetron Odt (Ondansetron) | Brand | 34 | 20 | $729 |
Hospital affiliations
Frequently asked questions
What is Dr. Hosam Saad-Naguib's medical specialty?
Dr. Hosam Saad-Naguib practices Hematology & Oncology Physician in Dalton, GA.
Where does Dr. Hosam Saad-Naguib practice?
Dr. Hosam Saad-Naguib practices at 1504 N Thornton Ave, Dalton, GA 307208394. Office phone: 7062260508.
What is Dr. Hosam Saad-Naguib's NPI?
Dr. Hosam Saad-Naguib's National Provider Identifier (NPI) is 1861473472, issued by NPPES.
Does Dr. Hosam Saad-Naguib accept Medicare assignment?
Yes. Dr. Hosam Saad-Naguib accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Hosam Saad-Naguib commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.